BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11410501)

  • 1. Diagnostic strategy for analytical scanning of BRCA1 gene by fluorescence-assisted mismatch analysis using large, bifluorescently labeled amplicons.
    Ricevuto E; Sobol H; Stoppa-Lyonnet D; Gulino A; Marchetti P; Ficorella C; Martinotti S; Meo T; Tosi M
    Clin Cancer Res; 2001 Jun; 7(6):1638-46. PubMed ID: 11410501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
    Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
    Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.
    Hogervorst FB; Nederlof PM; Gille JJ; McElgunn CJ; Grippeling M; Pruntel R; Regnerus R; van Welsem T; van Spaendonk R; Menko FH; Kluijt I; Dommering C; Verhoef S; Schouten JP; van't Veer LJ; Pals G
    Cancer Res; 2003 Apr; 63(7):1449-53. PubMed ID: 12670888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
    Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
    Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
    Kringen P; Egedal S; Pedersen JC; Harbitz TB; Tveit KM; Berg K; Børresen-Dale AL; Andersen TI
    Electrophoresis; 2002 Dec; 23(24):4085-91. PubMed ID: 12481264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.
    Casadei S; Cortesi L; Pensotti V; Radice P; Pierotti M; Amadori D; Calistri D
    Br J Cancer; 2001 Sep; 85(6):845-9. PubMed ID: 11556835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation scanning of exon 20 of the BRCA1 gene by high-resolution melting curve analysis.
    Vorkas PA; Christopoulos K; Kroupis C; Lianidou ES
    Clin Biochem; 2010 Jan; 43(1-2):178-85. PubMed ID: 19747471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of germline mutations in the BRCA1 gene by RNA-based sequencing.
    Jakubowska A; Górski B; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Debniak T; Hadaczek P; Scott RJ; Lubinski J
    Hum Mutat; 2001 Aug; 18(2):149-56. PubMed ID: 11462239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
    Barker DF
    Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
    Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
    Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 germline mutations in Indian familial breast cancer.
    Valarmathi MT; A A; Deo SS; Shukla NK; Das SN
    Hum Mutat; 2003 Jan; 21(1):98-9. PubMed ID: 12497638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for large rearrangements of the BRCA1 gene in German breast or ovarian cancer families using semi-quantitative multiplex PCR method.
    Hofmann W; Görgens H; John A; Horn D; Hüttner C; Arnold N; Scherneck S; Schackert HK
    Hum Mutat; 2003 Jul; 22(1):103-4. PubMed ID: 12815601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T
    Ann Acad Med Stetin; 2003; 49():27-43. PubMed ID: 15552838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting.
    van der Hout AH; van den Ouweland AM; van der Luijt RB; Gille HJ; Bodmer D; Brüggenwirth H; Mulder IM; van der Vlies P; Elfferich P; Huisman MT; ten Berge AM; Kromosoeto J; Jansen RP; van Zon PH; Vriesman T; Arts N; Lange MB; Oosterwijk JC; Meijers-Heijboer H; Ausems MG; Hoogerbrugge N; Verhoef S; Halley DJ; Vos YJ; Hogervorst F; Ligtenberg M; Hofstra RM
    Hum Mutat; 2006 Jul; 27(7):654-66. PubMed ID: 16683254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-exonic BRCA1 deletion identified in multiple families through single nucleotide polymorphism haplotype pair analysis and gene amplification with widely dispersed primer sets.
    Ward BD; Hendrickson BC; Judkins T; Deffenbaugh AM; Leclair B; Ward BE; Scholl T
    J Mol Diagn; 2005 Feb; 7(1):139-42. PubMed ID: 15681486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer.
    Belogianni I; Apessos A; Mihalatos M; Razi E; Labropoulos S; Petounis A; Gaki V; Keramopoulos A; Pandis N; Kyriacou K; Hadjisavvas A; Kosmidis P; Yannoukakos D; Nasioulas G
    BMC Cancer; 2004 Sep; 4():61. PubMed ID: 15353005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers.
    Arnold N; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Kiechle M
    Hum Mutat; 1999; 14(4):333-9. PubMed ID: 10502781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.